292 related articles for article (PubMed ID: 8390684)
1. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.
Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684
[TBL] [Abstract][Full Text] [Related]
2. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
3. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.
Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D
Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
8. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
9. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.
Martinerie C; Huff V; Joubert I; Badzioch M; Saunders G; Strong L; Perbal B
Oncogene; 1994 Sep; 9(9):2729-32. PubMed ID: 7520150
[TBL] [Abstract][Full Text] [Related]
11. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
[TBL] [Abstract][Full Text] [Related]
12. The regulation of IGF-I receptor gene expression by positive and negative zinc-finger transcription factors.
Werner H; Roberts CT; LeRoith D
Adv Exp Med Biol; 1993; 343():91-103. PubMed ID: 8184747
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
[TBL] [Abstract][Full Text] [Related]
15. The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein.
Karnieli E; Werner H; Rauscher FJ; Benjamin LE; LeRoith D
J Biol Chem; 1996 Aug; 271(32):19304-9. PubMed ID: 8702614
[TBL] [Abstract][Full Text] [Related]
16. Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression.
Roberts CT
Endocr J; 1996 Oct; 43 Suppl():S49-55. PubMed ID: 9076342
[TBL] [Abstract][Full Text] [Related]
17. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
18. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
19. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumor protein (-KTS) modulates renin gene transcription.
Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
